Tracking the KURA option chain helps you see every strike and expiry on Kura Oncology Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Kura Oncology Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of KURA options activity at a glance. Use our scanner to monitor the KURA option chain in real time and filter for the KURA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For KURA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the KURA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where KURA stock options are being actively traded and where they are not.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications.
The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Kura Oncology Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen KURA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of KURA stock options — let the full option chain come to you, pre-filtered and ready to trade.
